Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B known ✓ | P41595 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.56 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 8/20 | 0.52 |
| ▸ | RAB9A | P51151 | 8/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.52 |
| ▸ | MEN1 | O00255 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.45 |
| ▸ | POLB | P06746 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.44 |
| ▸ | RELA | Q04206 | 2/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10327418 | 0.99 | CASP3 (0.57) | CASP3SENP8SENP7SENP6NPC1 | |
| SCHEMBL3274206 | 0.87 | MEN1 (0.57) | CASP3SENP8SENP7SENP6NPC1 | |
| SCHEMBL22901136 | 0.81 | MEN1 (0.44) | CASP3SENP8SENP7SENP6NPC1 | |
| Acetic Acid SCHEMBL313911 | 0.79 | KMT2A (0.45) | CASP3SENP8SENP7SENP6NPC1 | |
| SCHEMBL3275818 | 0.74 | MEN1 (0.53) | CASP3SENP8SENP7SENP6NPC1 | |
| SCHEMBL826022 | 0.74 | KMT2A (0.45) | NPC1RAB9AKMT2AMEN1KDM4E | |
| SCHEMBL14347198 | 0.72 | RAB9A (0.62) | CASP3SENP8SENP7SENP6NPC1 | |
| SCHEMBL28432579 | 0.72 | MEN1 (0.55) | NPC1RAB9AKMT2AMEN1KDM4E | |
| SCHEMBL17153952 | 0.71 | NPC1 (0.66) | CASP3SENP8SENP7SENP6NPC1 | |
| Perchlorate SCHEMBL29361888 | 0.71 | KMT2A (0.41) | NPC1RAB9AKMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 453 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240011099-A1 | STAINED BIOLOGICAL SPECIMENS INCLUDING ONE OR MORE BIOMARKERS LABELED WITH ONE OR MORE DETECTABLE MOIETIES | VENTANA MED SYST INC (US) | 2024-01-11 | — | — | US | claimed |
| EP-4281779-A1 | STAINED BIOLOGICAL SPECIMENS INCLUDING ONE OR MORE BIOMARKERS LABELED WITH ONE OR MORE DETECTABLE MOIETIES | Ventana Medical Systems, Inc. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230014031-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING | ESSENLIX CORPORATION (US) | 2023-01-19 | — | — | US | claimed |
| US-11543408-B2 | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | ESSENLIX CORPORATION (US) | 2023-01-03 | — | — | US | claimed |
| US-11326989-B2 | Devices and methods for tissue and cell staining | ESSENLIX CORPORATION (US) | 2022-05-10 | — | — | US | claimed |
| US-20200378875-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING | ESSENLIX CORPORATION (US) | 2020-12-03 | — | — | US | claimed |
| EP-3700420-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING | Essenlix Corporation (US) | 2020-09-02 | — | — | EP | claimed |
| US-20200049701-A1 | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | ESSENLIX CORPORATION (US) | 2020-02-13 | — | — | US | claimed |
| US-20170112829-A1 | USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2017-04-27 | — | — | US | claimed |
| US-20110052723-A1 | USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2011-03-03 | — | — | US | claimed |
| EP-0268766-B1 | METHOD OF CLASSIFYING LEUKOCYTES BY FLOW CYTOMETRY AND REAGENTS USED IN THE METHOD | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1993-06-16 | — | — | EP | claimed |
| US-5179026-A | Optical measurement on fluorochrome stained blood cell; measuring signals of right angle scattering, medical diagnosis | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1993-01-12 | — | — | US | claimed |
| EP-0513762-A1 | Reagent and method for analyzing cells in urine | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1992-11-19 | — | — | EP | claimed |
| EP-0499693-A2 | Method of differentiating erythroblasts from other cells by flow cytometry | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1992-08-26 | — | — | EP | claimed |
| EP-0259834-B1 | METHOD OF CLASSIFYING LEUCOCYTES BY FLOW CYTOMETRY | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1992-08-12 | — | — | EP | claimed |
| EP-0485945-A2 | Method of classifying leukocytes by flow cytometry | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1992-05-20 | — | — | EP | claimed |
| EP-0483116-A2 | Method of classifying leukocytes by flow cytometry and reagents used in the method | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1992-04-29 | — | — | EP | claimed |
| US-5039613-A | Using optical measurements | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1991-08-13 | — | — | US | claimed |
| EP-0268766-A2 | Method of classifying leukocytes by flow cytometry and reagents used in the method | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1988-06-01 | — | — | EP | claimed |
| EP-0259834-A2 | Method of classifying leucocytes by flow cytometry | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1988-03-16 | — | — | EP | claimed |